Top compounds associated with response to CTC-479C5.6


Feature Type Standardized
Nominal ANOVA
mRNA EX-527 CTRPv2 pan-cancer AAC 0.084 0.03
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC -0.12 0.03
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.03
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.03
mRNA cediranib CTRPv2 pan-cancer AAC -0.11 0.03
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.074 0.03
mRNA necrosulfonamide CTRPv2 pan-cancer AAC -0.08 0.03
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.04
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.04
Download CSV